MATAURO’s Eli Lilly LLY Stock Holding History

MATAURO’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.83M	Buy	1,578 +1,062	+206%	+$1.25M	0.22%	58
2026 Q2	$619K	Buy	+516	New	+$527K	0.08%	96

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Bank Julius Baer & Co Zurich, Switzerland $39.3B AUM 31.81% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

MATAURO's LLY Position: Q3 2026 in Review

MATAURO increased its Eli Lilly (LLY) stake by 206% in Q3 2026, buying an estimated $1.25M and bringing the position to 1,578 shares worth $1.83M. The position accounts for 0.22% of the portfolio, ranked #58.

MATAURO first reported a position in LLY in Q2 2026 and has held it in 2 quarters since. 2,398 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

MATAURO held 1,578 shares of Eli Lilly worth $1.83M as of Q3 2026.
MATAURO bought 1,062 Eli Lilly shares in Q3 2026, an estimated $1.25M.
Eli Lilly made up 0.22% of MATAURO's portfolio in Q3 2026, its #58 holding.
MATAURO first reported a position in Eli Lilly in Q2 2026 and has held it in 2 quarters since.
2,398 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on MATAURO's 13F filing for Q3 2026, filed 3 Nov 2026.